SPAC343.20 Antibody

What is SPAC343.20 and what is known about its function?

SPAC343.20 is an uncharacterized protein found in Schizosaccharomyces pombe (fission yeast, strain 972/ATCC 24843). While the precise function of this protein remains to be fully elucidated, it is part of ongoing research in S. pombe proteomics. The protein is identified in UniProt with the accession number Q9C111 . Based on sequence analysis and comparison with other S. pombe proteins, there may be similarities to meiotic proteins, as several proteins with similar systematic names (like SPAC343.07, also known as mug28+) have been implicated in meiotic processes . Research into its molecular function, biological processes, and cellular components is still evolving, making antibodies against this protein valuable tools for functional characterization studies.

What types of SPAC343.20 antibodies are available for research?

Currently, polyclonal antibodies raised against recombinant Schizosaccharomyces pombe SPAC343.20 protein are available for research purposes. These antibodies are typically produced in rabbits using purified recombinant SPAC343.20 protein as the immunogen . The polyclonal nature of these antibodies means they recognize multiple epitopes on the target protein, which can be advantageous for detection in various applications. For researchers interested in studying this protein, antibodies with product codes such as CSB-PA887196XA01SXV are available . These are typically purified using antigen affinity methods to enhance specificity.

What are the recommended storage and handling conditions for SPAC343.20 antibody?

For optimal stability and performance, SPAC343.20 antibody should be stored at either -20°C or -80°C upon receipt . Repeated freeze-thaw cycles should be avoided as they can degrade the antibody and reduce its efficacy. The antibody is typically supplied in liquid form with a storage buffer containing preservatives and stabilizers, specifically 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4 . For routine use, it's advisable to prepare working aliquots to minimize freeze-thaw cycles of the stock solution. When handling the antibody, standard laboratory practices for protein solutions should be followed, including the use of clean pipette tips and microcentrifuge tubes to prevent contamination.

What experimental applications have been validated for SPAC343.20 antibody?

SPAC343.20 antibody has been validated for several experimental applications, including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) . These techniques are fundamental for protein detection and quantification in research settings. The antibody's suitability for these applications suggests it can effectively recognize the native or denatured forms of the protein depending on the specific experimental conditions. While these are the primarily validated applications, researchers might explore its utility in other immunological techniques such as immunoprecipitation, immunohistochemistry, or flow cytometry, though additional validation would be necessary for these applications.

How should Western blot protocols be optimized for SPAC343.20 detection?

When optimizing Western blot protocols for SPAC343.20 detection, several parameters should be carefully considered. Based on approaches used for similar S. pombe proteins, researchers should first consider sample preparation. For total protein extraction from S. pombe, methods involving mechanical disruption of cells (such as glass bead lysis) in the presence of protease inhibitors are recommended to preserve protein integrity.

For gel electrophoresis, a 10-12% SDS-PAGE gel is typically suitable for resolving proteins in the expected molecular weight range of SPAC343.20. After transfer to a nitrocellulose or PVDF membrane, blocking should be performed with 5% non-fat dry milk or bovine serum albumin in TBST (Tris-buffered saline with 0.1% Tween-20).

For primary antibody incubation, start with a 1:1000 dilution of SPAC343.20 antibody and optimize as needed. Incubate overnight at 4°C for best results. After washing, use an appropriate HRP-conjugated secondary antibody against rabbit IgG. For detection, both chemiluminescence and fluorescence-based methods can be employed, with exposure times adjusted based on signal intensity. Include positive controls (recombinant SPAC343.20 protein if available) and negative controls (lysates from SPAC343.20 knockout strains if available) to validate specificity .

What considerations are important for RNA-binding protein analysis if SPAC343.20 has RNA-binding properties?

If SPAC343.20 is suspected to have RNA-binding properties (which might be the case given similarities to other S. pombe proteins like zfs1 or mug28), several specialized techniques should be considered. RNA gel shift assays (also known as electrophoretic mobility shift assays or EMSAs) can be used to assess direct binding between purified recombinant SPAC343.20 protein and RNA sequences of interest .

For these assays, recombinant SPAC343.20 protein can be produced using expression systems similar to those used for other S. pombe proteins. For instance, cloning the SPAC343.20 coding region into an expression vector with a maltose-binding protein (MBP) tag has proven effective for similar proteins . The protein should be purified using affinity chromatography, with protein concentration and purity confirmed by SDS-PAGE.

For RNA probes, synthetic oligonucleotides representing potential binding sequences can be end-labeled with [32P]pCp using T4 RNA ligase. In binding reactions, approximately 100 fmol of labeled probe should be incubated with increasing concentrations of purified SPAC343.20 protein. The reactions should be analyzed by non-denaturing polyacrylamide gel electrophoresis. Controls should include mutated versions of the RNA sequence and unrelated RNA sequences to demonstrate binding specificity .

How can researchers design studies to investigate SPAC343.20's role during meiosis?

To investigate SPAC343.20's potential role during meiosis in S. pombe, researchers should consider a comprehensive approach combining genetic, biochemical, and cell biological techniques. Given that some similarly named proteins like SPAC343.07 (mug28+) have meiotic functions, this is a reasonable avenue for exploration .

First, expression analysis should be performed to determine if SPAC343.20 transcript or protein levels change during meiosis. This can be accomplished using Northern blotting for RNA levels or Western blotting with SPAC343.20 antibody for protein levels in synchronized meiotic cultures .

Gene deletion studies are essential to determine if SPAC343.20 is required for normal meiotic progression. A SPAC343.20 knockout strain should be created and assessed for defects in meiotic processes including DNA replication, recombination, chromosome segregation, and spore formation. Complementary to this, fluorescence microscopy using GFP-tagged SPAC343.20 can reveal its subcellular localization during different meiotic stages, similar to approaches used for other meiotic proteins like Meu14-GFP .

For advanced functional analysis, researchers might consider creating specific mutations in conserved domains of SPAC343.20 to identify critical residues for its function, similar to the site-directed mutagenesis approach used for the zinc finger protein zfs1 .

What approaches can be used to identify interaction partners of SPAC343.20?

To identify interaction partners of SPAC343.20, several complementary approaches should be employed. Immunoprecipitation (IP) using SPAC343.20 antibody followed by mass spectrometry analysis is a powerful technique for identifying protein-protein interactions in vivo. For this approach, S. pombe cells should be lysed under conditions that preserve native protein complexes, and SPAC343.20 antibody can be used to pull down the target protein along with its interacting partners .

Yeast two-hybrid (Y2H) screening offers another strategy for detecting binary protein-protein interactions. The SPAC343.20 coding sequence would be cloned into a bait vector and screened against a library of S. pombe proteins in prey vectors. Positive interactions can be further validated using techniques like co-immunoprecipitation.

If SPAC343.20 is involved in RNA metabolism (similar to zfs1), RNA immunoprecipitation (RIP) or crosslinking immunoprecipitation (CLIP) can be performed to identify target RNAs. In this approach, SPAC343.20 antibody is used to immunoprecipitate the protein along with bound RNAs, which are then identified by sequencing .

For a more global view of the SPAC343.20 interactome, BioID or proximity labeling techniques could be employed, wherein SPAC343.20 is fused to a biotin ligase that biotinylates proteins in close proximity, allowing for their subsequent purification and identification.

How can researchers analyze the effects of stress conditions on SPAC343.20 expression and function?

To analyze how stress conditions affect SPAC343.20 expression and function, researchers should design experiments that combine exposure to various stressors with comprehensive molecular and cellular analyses. Given that some S. pombe proteins show altered expression or activity under stress conditions (like iron depletion for zfs1 ), this is a relevant area of investigation.

First, quantitative RT-PCR and Western blotting with SPAC343.20 antibody should be used to monitor changes in SPAC343.20 mRNA and protein levels under various stress conditions (oxidative stress, nutrient limitation, temperature shifts, etc.) . Time-course experiments can reveal the dynamics of these changes.

For functional analysis, phenotypic assays comparing wild-type and SPAC343.20 deletion strains under stress conditions can reveal stress-specific requirements for the protein. If SPAC343.20 is involved in post-transcriptional regulation like zfs1, changes in the stability of target transcripts under stress can be assessed using transcriptional inhibition followed by RNA quantification .

If specific stress conditions alter SPAC343.20 expression, promoter analysis can identify stress-responsive elements. This could involve creating reporter constructs with the SPAC343.20 promoter driving expression of a fluorescent protein, followed by systematic mutation of promoter elements to identify those responsible for stress responsiveness.

What techniques can be used to analyze post-translational modifications of SPAC343.20?

Analysis of post-translational modifications (PTMs) of SPAC343.20 requires specialized techniques that can detect and characterize these chemical changes. Immunoprecipitation using SPAC343.20 antibody followed by mass spectrometry analysis is the gold standard for comprehensive PTM mapping . This approach can identify various modifications including phosphorylation, acetylation, ubiquitination, and SUMOylation, along with their specific sites.

For phosphorylation analysis, researchers can use phospho-specific antibodies (if available) in Western blotting. Alternatively, immunoprecipitated SPAC343.20 can be treated with phosphatases and changes in electrophoretic mobility observed. Phos-tag SDS-PAGE is another useful technique that can separate phosphorylated and non-phosphorylated forms of the protein.

To determine if PTMs affect SPAC343.20 function, mutational analysis can be performed where potential modification sites are mutated to non-modifiable residues (e.g., serine to alanine for phosphorylation sites). These mutants can then be tested for their ability to complement SPAC343.20 deletion phenotypes.

Cell cycle synchronization experiments can reveal if SPAC343.20 undergoes cell cycle-dependent modifications, which would be particularly relevant if the protein has meiotic functions similar to mug28+ .

What are common issues with SPAC343.20 antibody in Western blotting and how can they be resolved?

When working with SPAC343.20 antibody in Western blotting, researchers may encounter several common issues. One frequent problem is weak or absent signal, which can be addressed by optimizing antibody concentration (try a range from 1:500 to 1:5000), increasing incubation time, or using more sensitive detection methods . If protein loading is sufficient (confirm with loading controls), consider alternative extraction methods to ensure the protein is efficiently released from cells.

High background is another common issue that can be mitigated by increasing blocking time or concentration (try 5% BSA instead of milk for phospho-proteins), adding 0.1-0.3% Tween-20 to wash buffers, and performing more thorough washing steps. If nonspecific bands appear, try more stringent washing conditions or lower primary antibody concentration. Pre-adsorbing the antibody with bacterial or yeast lysates lacking SPAC343.20 can also reduce non-specific binding.

Multiple bands might indicate protein degradation (add fresh protease inhibitors to lysis buffer), post-translational modifications (confirm with appropriate controls), or cross-reactivity. For cross-reactivity issues, increasing the stringency of washing conditions or using a different clone of antibody might help .

If detecting endogenous SPAC343.20 proves challenging due to low expression levels, consider enrichment strategies such as immunoprecipitation before Western blotting or using overexpression systems for initial characterization.

How can researchers validate the specificity of SPAC343.20 antibody in their experimental system?

Validating the specificity of SPAC343.20 antibody is critical for ensuring reliable experimental results. Several approaches should be considered for comprehensive validation. First, include appropriate positive and negative controls in your experiments. A recombinant SPAC343.20 protein can serve as a positive control, while lysates from SPAC343.20 knockout strains provide an ideal negative control .

Peptide competition assays offer another validation method, wherein the antibody is pre-incubated with excess immunizing peptide or recombinant protein before application to the sample. Specific signals should be significantly reduced or eliminated in this competition experiment.

For genetic validation, compare antibody reactivity across wild-type and genetically modified S. pombe strains (knockout, knockdown, or overexpression of SPAC343.20). The signal intensity should correlate with expected protein levels in each strain.

Parallel validation using multiple detection methods is also recommended. If an antibody works in both Western blotting and immunofluorescence with consistent localization patterns as predicted by bioinformatics or reported in literature, this provides stronger evidence for specificity .

For definitive validation, immunoprecipitation followed by mass spectrometry can confirm that the antibody is indeed pulling down SPAC343.20 and not cross-reacting with other proteins.

What experimental design considerations are important when studying potential SPAC343.20 mutants?

When designing experiments to study SPAC343.20 mutants, several key considerations should be addressed for rigorous scientific investigation. First, carefully select the mutation strategy based on the research question. For structure-function analysis, consider creating point mutations in conserved domains (similar to the C370G and H351I mutations created in zfs1 ). For complete loss-of-function studies, gene deletion or CRISPR-based disruption might be more appropriate.

Include appropriate controls in all experiments. This should include wild-type strains processed in parallel with mutants, as well as complementation controls where the wild-type gene is reintroduced to confirm that observed phenotypes are specifically due to SPAC343.20 mutation.

When analyzing phenotypes, employ multiple complementary approaches. For example, if studying meiotic functions, combine microscopy to observe cellular events with molecular assays to monitor biochemical processes and genetic assays to measure outcomes like spore viability .

Consider potential redundancy with related proteins. If SPAC343.20 belongs to a protein family, single mutants might show subtle phenotypes due to functional compensation by related proteins. In such cases, creating double or triple mutants might be necessary to uncover function.

How should researchers interpret contradictory results between different antibody-based assays?

When faced with contradictory results between different antibody-based assays using SPAC343.20 antibody, a systematic troubleshooting approach is essential. First, consider that different assays detect proteins in different states: Western blotting detects denatured proteins, while immunoprecipitation and immunofluorescence typically detect proteins in more native conformations. Therefore, epitope accessibility may vary between assays .

Begin by validating the antibody's specificity in each assay independently using appropriate controls. For contradictions between detection methods, examine whether post-translational modifications might explain the discrepancies. Some antibodies may preferentially recognize modified or unmodified forms of the protein.

Sample preparation differences can also lead to contradictory results. For instance, certain extraction methods might better preserve protein-protein interactions or subcellular compartmentalization. Crosslinking agents used in some protocols can also affect epitope recognition .

Consider biological variables that might explain discrepancies, such as cell cycle stage, growth conditions, or stress responses that could affect SPAC343.20 expression, localization, or modification state. If contradictions persist despite thorough troubleshooting, consider using alternative approaches like epitope tagging of endogenous SPAC343.20 to bypass potential antibody specificity issues.

What are the best practices for quantifying Western blot results with SPAC343.20 antibody?

For accurate quantification of Western blot results using SPAC343.20 antibody, several best practices should be followed. Start with proper experimental design: include a dilution series of samples to ensure measurements fall within the linear range of detection, and run technical replicates across multiple blots for statistical validation .

Appropriate loading controls are critical. For total protein normalization, consider using housekeeping proteins like actin that remain relatively stable across experimental conditions . Alternatively, total protein staining methods (Ponceau S, SYPRO Ruby, etc.) before immunoblotting can provide more reliable normalization.

For image acquisition, use a digital imaging system with a dynamic range appropriate for the signal intensity. Avoid saturated pixels, which prevent accurate quantification. When using chemiluminescence detection, capture multiple exposures to ensure measurements are made from unsaturated images .

For data analysis, use specialized software that can perform background subtraction and normalization. Define regions of interest consistently across all lanes and blots. Express SPAC343.20 levels relative to loading controls and normalize to appropriate reference conditions (e.g., untreated samples or wild-type strains).

Statistical analysis should account for technical and biological variability. Report means with standard deviations or standard errors from at least three independent biological replicates, and use appropriate statistical tests to assess significance of observed differences .

How can researchers integrate SPAC343.20 data with other -omics datasets for systems-level analysis?

Integrating SPAC343.20 data with other -omics datasets can provide valuable insights into the protein's function within broader cellular networks. Begin by collecting relevant datasets, including transcriptomics (RNA-seq), proteomics, phosphoproteomics, and interaction datasets (protein-protein, protein-DNA, or protein-RNA interactions) from wild-type and SPAC343.20 mutant S. pombe strains under conditions of interest.

For integrative analysis, correlation approaches can identify genes or proteins with expression patterns similar to SPAC343.20 across various conditions, potentially revealing co-regulated functional modules. Network analysis tools can place SPAC343.20 within protein-protein interaction networks, helping to identify functional clusters and potential regulatory relationships.

If SPAC343.20 is suspected to have RNA-binding properties like zfs1 , integrate transcriptome data with RNA immunoprecipitation sequencing (RIP-seq) results to identify direct RNA targets and correlate binding with changes in target RNA stability or translation.

For temporal dynamics, integrate time-course data across multiple -omics layers to understand how SPAC343.20 function changes during processes like the cell cycle, meiosis, or stress responses . This could reveal, for instance, whether SPAC343.20 protein modifications precede changes in target gene expression.